Total Payments
$5,292
2024 Payments
$1,547
Companies
42
Transactions
323
Medicare Patients
270
Medicare Billing
$19,853
Payment Breakdown by Category
Food & Beverage$5,270 (99.6%)
Education$21.74 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,270 | 322 | 99.6% |
| Education | $21.74 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $900.64 | 60 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $753.35 | 32 | $0 (2024) |
| Lilly USA, LLC | $451.98 | 31 | $0 (2024) |
| PFIZER INC. | $326.45 | 20 | $0 (2024) |
| Daiichi Sankyo Inc. | $301.73 | 18 | $0 (2024) |
| Novo Nordisk Inc | $268.80 | 21 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $250.77 | 18 | $0 (2024) |
| Amgen Inc. | $172.80 | 10 | $0 (2024) |
| Mylan Specialty L.P. | $159.28 | 9 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $140.74 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,547 | 90 | AstraZeneca Pharmaceuticals LP ($356.04) |
| 2023 | $1,023 | 60 | ABBVIE INC. ($280.32) |
| 2022 | $1,219 | 67 | AstraZeneca Pharmaceuticals LP ($265.68) |
| 2021 | $1,502 | 106 | AbbVie Inc. ($324.88) |
All Payment Transactions
323 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $19.03 | General |
| Category: Iron Deficiency Anemia | ||||||
| 12/17/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $21.55 | General |
| Category: Endocrinology | ||||||
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.83 | General |
| Category: DIABETES | ||||||
| 12/04/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 12/02/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: Central Nervous System | ||||||
| 11/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/07/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $26.83 | General |
| Category: Cardiology | ||||||
| 11/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.60 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.63 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: Diabetes | ||||||
| 10/22/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: VACCINE | ||||||
| 10/17/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $22.78 | General |
| Category: Inflammation | ||||||
| 10/09/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: PAIN | ||||||
| 10/07/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: RESPIRATORY | ||||||
| 10/02/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $21.72 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/01/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: Diabetes | ||||||
| 09/30/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: PSYCHIATRY | ||||||
| 09/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.31 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 183 | 271 | $34,405 | $14,153 |
| 2022 | 2 | 87 | 120 | $14,150 | $5,700 |
Total Patients
270
Total Services
391
Medicare Billing
$19,853
Procedure Codes
8
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 59 | 67 | $11,425 | $4,881 | 42.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 71 | 90 | $11,195 | $3,755 | 33.5% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 19 | 48 | $4,800 | $2,267 | 47.2% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 12 | 44 | $4,400 | $1,978 | 45.0% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 11 | 11 | $2,090 | $954.03 | 45.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 11 | 11 | $495.00 | $317.90 | 64.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 73 | 86 | $10,750 | $4,183 | 38.9% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 14 | 34 | $3,400 | $1,516 | 44.6% |
About Kelley Scott
Kelley Scott is a Family healthcare provider based in Toronto, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/20/2015. The National Provider Identifier (NPI) number assigned to this provider is 1396116109.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kelley Scott has received a total of $5,292 in payments from pharmaceutical and medical device companies, with $1,547 received in 2024. These payments were reported across 323 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($5,270).
As a Medicare-enrolled provider, Scott has provided services to 270 Medicare beneficiaries, totaling 391 services with total Medicare billing of $19,853. Data is available for 2 years (2022–2023), covering 8 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Other Specialties Family, Family
- Location Toronto, OH
- Active Since 10/20/2015
- Last Updated 11/02/2016
- Taxonomy Code 363LF0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1396116109
Products in Payments
- VRAYLAR (Drug) $592.64
- INJECTAFER (Drug) $301.73
- FARXIGA (Drug) $294.34
- ELIQUIS (Drug) $252.93
- MOUNJARO (Drug) $222.32
- XARELTO (Drug) $216.22
- BRILINTA (Drug) $214.06
- UBRELVY (Drug) $191.78
- YUPELRI (Drug) $159.28
- NURTEC ODT (Drug) $153.14
- BREZTRI (Drug) $129.38
- Ozempic (Drug) $126.13
- TRINTELLIX (Drug) $118.67
- ENTRESTO (Drug) $118.02
- AIRSUPRA (Drug) $115.57
- EMGALITY (Drug) $110.45
- JARDIANCE (Drug) $102.67
- Otezla (Drug) $99.19
- TRELEGY ELLIPTA (Drug) $93.91
- VERQUVO (Drug) $91.53
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.